News
Paragraf and Archer Materials announce strategic collaboration on graphene‑based quantum devices
Paragraf, a leader in graphene electronics and fabrication, and Archer Materials Ltd., a technology company specializing in advanced materials and quantum‑enabling devices, has announced a cooperative research and development program focused on next‑generation quantum computing hardware enabled by graphene‑based device platforms. The collaboration brings together Paragraf’s commercially scalable graphene platform
Read More
PlanetiQ awarded $15M U.S. Air Force STRATFI contract to advance next-generation weather data from space
PlanetiQ has announced it has been awarded a $15 million, 48-month Strategic Funding Increase (STRATFI) contract by the U.S. Air Force. The program will support the development and launch of spacecraft equipped with next-generation Global Navigation Satellite System (GNSS) RO, R and PRO instruments and the delivery of high-value weather
Read More
Glydways raises oversubscribed $170M Series C as first autonomous vehicle networks enter public operation in 2026
Glydways, the company delivering a new category of urban mobility, has announced its $170 million Series C fundraise. The round was co-led by Suzuki Motor Corporation, ACS Group, and Khosla Ventures with additional participation from existing investors Mitsui Chemicals and Gates Frontier, and new investor, Obayashi Corporation, a leading general
Read More
Resolve Therapeutics and Institut Pasteur collaborate to identify Cell-Free RNA triggers in autoimmunity
Resolve Therapeutics, a next-generation biopharma company transforming the treatment of autoimmune diseases with innovative non-immunosuppressive drugs (resolvetherapeutics.com) and the Institut Pasteur de Montevideo, the premier basic science laboratory at the forefront of cfRNA in human disease (pasteur.uy), will collaborate to identify the central upstream triggers that drive inflammation in autoimmune
Read More
Novadip announces the implantation of the first two patients in its phase 3 pivotal trial of NVD003 in CPT
During February and March 2026, the first two patients enrolled in Novadip's pivotal phase 3 trial for the treatment of Congenital Pseudarthrosis of the Tibia (CPT) were successfully implanted with NVD003 in Belgium and the US. NVD003, an autologous bone graft created from a patient’s own adipose stem cells, is
Read More
Antevia Networks and Benetel sign strategic partnership to accelerate scalable, mission-critical outdoor private 5G
Antevia Networks™, the telecoms equipment vendor changing the economics of 5G private networks, has announced the signing of a strategic partnership with Benetel, an Irish manufacturer of O-RAN compliant radio units. The agreement follows successful integration testing of Benetel’s outdoor O-RU with Antevia’s 5G SHIFT™ private network platform, enabling customers
Read More
NorthSea Therapeutics announces achievement of key regulatory milestones for Orziloben
NorthSea Therapeutics B.V. (“NorthSea” or the “Company”), a private, late-stage clinical biotechnology company leveraging its proprietary structurally engineered fatty acids (SEFAs) platform to develop novel drugs to treat rare liver diseases, has announced that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency’s (EMA) Committee for Orphan
Read More
Hitachi Energy and Pakal Technologies join forces in breakthrough silicon power semiconductor for high-voltage modules
Hitachi Energy, a global leader in electrification, and Pakal Technologies, a cutting-edge innovator in silicon power semiconductor design, announced a collaboration to advance shared value creation and sustainable growth. Hitachi Energy will incorporate Pakal Technologies’ groundbreaking Insulated Gate Turn-Off (Thyristor), IGTO(t)™, silicon power switch into its portfolio of market-leading high-voltage
Read More
biomodal and Element Biosciences combine duet multiomic and high-throughput sequencing capabilities to advance clinical research
biomodal, an omics-based life sciences technology and analytics company, announced at the AGBT 2026 General Meeting that biomodal’s duet multiomic solutions are compatible with Element Biosciences AVITI24™ 5D multiomics and AVITI™ sequencing instruments. Validated at the University of Minnesota (UMN) Genomics Center, this integration delivers enhanced sensitivity for applications including
Read More
VORAGO and wolfSSL partner on cybersecurity and radiation protection for a scaling space economy at SmallSat Symposium 2026
At SmallSat Symposium 2026, VORAGO Technologies, a radiation-hardened and radiation-tolerant chip provider for space applications, announced a software partnership with wolfSSL, a company specializing in embedded cryptography for secure systems successfully for the last 20 years. This unique partnership delivers radiation-hardened chips with built-in, standards-based cryptographic security for orbital missions,
Read MoreGlydways breaks ground on first ever public mass transit system in South Metro Atlanta
Glydways, a leading global Automated Transit Network (ATN), today announced a historic milestone in global mobility as they officially broke ground on its first publicly accessible system in South Metro Atlanta. Revealed during the South Metro Development Outlook Conference (SMDO26) in collaboration with ATL Airport Community Improvement Districts (AACIDs), the
Read MoreSigning an agreement to launch first automated transit network programme with Glydways
Dubai’s Roads and Transport Authority (RTA) has signed a cooperation agreement with Glydways, a global leader in Automated Transit Networks (ATN). The agreement marks the launch of the first automated programme for an automated transit network, introducing a new model of smart and sustainable mobility in Dubai. The initiative supports
Read More